Table 1 Baseline characteristics of the 85 patients treated in intensive care units due to a SARS-CoV-2 infection
From: Lung function and exercise capacity 6 months after hospital discharge for critical COVID-19
N = 85 | |
|---|---|
Sex | |
Male | 52 (61%) |
Female | 33 (39%) |
Age, years | 60 (50–68) |
BMI, kg/m2 | 30.1 (27.2–34.3) |
Smoking | |
Never | 56 (65%) |
Former | 29 (34%) |
Current | 0 (0%) |
Comorbidities | |
One or more comorbidities | 67 (78%) |
Hypertension | 49 (58%) |
Dyslipidaemia | 29 (34%) |
Type 1 diabetes | 2 (2%) |
Type 2 diabetes | 18 (21%) |
CAD or PAD | 12 (14%) |
Atrial fibrillation | 4 (5%) |
Previous DVT/PE or thrombophilia | 8 (9%) |
Chronic kidney failure | 3 (4%) |
Asthma | 13 (15%) |
COPD | 1 (1%) |
Obstructive sleep apnoea | 14 (17%) |
Hypothyroidism | 5 (6%) |
Rheumatoid arthritis | 6 (7%) |
Gout | 5 (6%) |
Cancer | 2 (2%) |
Neurological disease | 2 (2%) |